Potential Cost-Shifting and Hidden Costs and Risks in the Economic Analysis of Opioid Abuse-Deterrent Formulations

Robert Twillman, Jeffrey Fudin
  • Pain Medicine, September 2014, Oxford University Press (OUP)
  • DOI: 10.1111/pme.12500

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/pme.12500

The following have contributed to this page: Dr Jeffrey Fudin